Clinical trial Recruiting at 4 sites Interventional Ages 18 to 70

Evaluating the effectiveness of spinal cord stimulation for chronic pain relief

Official title: Spinal Cord Stimulation for the Treatment of Therapy-Resistant Neuropathic Pain After Lumbar Spinal Surgery - A Randomized, Double-Blind, Sham-Controlled, Cross-over Study

Run by Sahlgrenska University Hospital · NCT06585033 · Data updated 2026-11-12

This study is testing if spinal cord stimulation can help people with chronic leg pain after back surgery feel better compared to a placebo treatment.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment50 (estimated)
SponsorSahlgrenska University Hospital
Academic / other
Locations4 sites (Arnhem and 3 other locations)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedDecember 2, 2025
Trial IDNCT06585033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-70 with chronic neuropathic leg pain following lumbar spinal surgery who have not responded to conservative treatments.

Probably not a fit

Patients with active implantable devices or those unable to operate the SCS device may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine whether spinal cord stimulation (SCS) is more effective than a placebo in reducing chronic postoperative neuropathic leg pain in patients who have undergone lumbar spinal surgery. The study employs a multicenter, double-blind, randomized, sham-controlled design, where participants will receive either active or subthreshold stimulation over a 12-month period. The primary outcome will be assessed through changes in leg pain intensity scores, alongside secondary measures including quality of life and medication use. Participants must demonstrate adequate pain relief during a preliminary test trial to qualify for the study.

Why it matters

Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from chronic postoperative pain.

How similar studies have gone: Previous randomized controlled trials have shown significant long-term pain reduction with spinal cord stimulation, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* History consistent with PSPS2 of at least 6 months after the last spinal surgery. The patient experienced no effect of conservative treatments and has been assessed as not eligible for further spinal surgery.
* Patients between 18-70 years of age.
* Average perceived pain intensity in one or both legs of 5 or more and average perceived pain intensity in the back of less than 3 measured with the validated 11-box NRS (0 no pain, 10 worst imaginable pain)
* The patient should have been informed verbally and in writing about the study and should have provided informed written consent to participate.
* Adequate pain relief effect (50% or more) after a two week trial with active test stimulation.

Exclusion Criteria:

* Subject is unable to understand or operate the SCS device.
* Subject currently has an active implantable device including pacemakers, spinal cord stimulator or intrathecal drug delivery system.
* Ongoing coagulation disorder.
* Ongoing abuse of alcohol, drugs, or prescription opioids.
* Active debilitating psychiatric illness.
* Active malignancy.
* Condition with increased general infection sensitivity, such as known immunodeficiency.
* Expected lifespan \<1 year.
* Ongoing local infection or other skin disease where the IPG is planned to be placed.
* Pregnancy.

Where it's running

  • Department of Anaesthesiology and Pain Management, Rijnstate Hospital
    Arnhem, Netherlands
    Recruiting
  • Department of Neurosurgery, Stavanger University hospital
    Stavanger, Norway
    Recruiting
  • Department of Neurosurgery, Sahlgrenska University Hospital
    Gothenburg, Sweden
    Recruiting
  • Department of Anesthesiology and Intensive Care/Pain Center, Sahlgrenska University Hospital Östra
    Gothenburg, Sweden
    Recruiting

Study contacts

  • Principal investigator: Kliment Gatzinsky, MD, PhD — Department of Neurosurgery, Sahlgrenska University Hospital
  • Study coordinator: Kliment Gatzinsky, MD, PhD
  • Email: kliment.gatzinsky@neuro.gu.se
  • Phone: +46733407733

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.